Efforts on to detect adverse drug reactions
The Pharmacovigilance Programme of India (PvPI), started nearly six years ago by the Central government, is meant to protect and promote public health in India.
The Regional Training Centre at Department of Clinical Pharmacology and Therapeutics at NIMS (Hyderabad), under the National Coordination Centre (NCC) of PvPI has organised a programme at the Andhra Medical College here on Saturday to create more awareness among the clinicians, pharamacists and pharmacologists of AP and Telangana States.
The PvPI would safeguard and enhance the safety of patients with respect to the use of drugs and devices including the alternate medicines like herbs which some times give adverse reaction as the patient would not reveal that he or she was taking the alternate medicine also, Coordinator of the training centre P. Usharani, who is also HoD of Clinical Pharmacology and Therapeutics at NIMS, has said.
The three areas where stress is being laid at present are collecting statistics since the data in the country is not available, detecting new signals on drug reaction and to bring in some regulatory changes or prescription changes, Dr. Usharani told The Hindu.
Efforts were on to detect new signals in the adverse drug reactions (ADRs). Some reactions may not be detected in the clinical trials since they are not done in large numbers. Drug labelling is changed and new prescriptions are given to the consumers in such cases. Anyone, including the patients, can report their experience by logging on to the Central Drugs Standard Control Organisation (CDSCO) website.
Genetic variation among the people of the country and dosage of medicines compared to the western countries are among the issues to be taken into consideration while collecting the data, she said.